News from kinex pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 17, 2014, 09:14 ET

Kinex Pharmaceuticals Appoints Chief Operating Officer

 Kinex Pharmaceuticals announced today that Mr. Flint Besecker has been appointed Chief Operating Officer of the company. Mr. Besecker will...

Oct 15, 2014, 07:56 ET

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results from a Phase I Clinical Study (HM-OTE-103) with Oratecan® in Patients with Advanced Cancer

 Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals announce today preliminary results from a Phase I Clinical Study of...

Sep 09, 2014, 07:43 ET

Kinex Completes Acquisition of QuaDPharma

 Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based...

Jul 24, 2014, 12:16 ET

Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)

 Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I...

Jul 01, 2014, 08:45 ET

Kinex Pharmaceuticals Appoints Mr. Michael Murphy to the Board of Directors

Kinex Pharmaceuticals announced today that Dr. Jean-Pierre Sommadossi has elected to step down from the Board of Directors of Kinex but...

Jun 30, 2014, 10:31 ET

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results on Oraxol® for Patients with Advanced Gastric Cancer from a Phase I/II Clinical Study

Hanmi Pharmaceuticals announces a positive study on Oraxol® use in a Phase I/II clinical proof-of-concept study (Study HM-OXL-201) of Oraxol -...

May 13, 2014, 09:00 ET

Kinex Pharmaceuticals Inc. Announces Key Additions to Clinical Leadership Team in Newly Formed Clinical Development Office in Cranford, New Jersey

Kinex Pharmaceuticals announces the addition of two key executives to its clinical leadership team reporting to Chief Medical Officer, Dr. Rudolf...

May 05, 2014, 09:00 ET

Kinex Receives US FDA Allowance for Oratecan, an Oral Form of Irinotecan with Enhanced Gastrointestinal Absorption, the Second U.S. IND Based on the Orascovery Technology Platform

 Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug...

Mar 19, 2014, 16:53 ET

Kinex and Zenith Technology to Initiate Clinical Studies of an Oral Form of Paclitaxel (Oraxol) in New Zealand

Kinex Pharmaceuticals announced today to having received regulatory and ethics approvals to initiate the first clinical study of an oral form of...

Mar 04, 2014, 12:53 ET

Kinex Completes Oversubscribed USD $40 Million Private Placement Equity Raise

 Kinex Pharmaceuticals announced today the successful completion of an oversubscribed USD $40 million private placement of equity which was...

Feb 06, 2014, 08:50 ET

Kinex and PharmaEssentia Expand Drug Development Partnership

 Kinex Pharmaceuticals and PharmaEssentia Corporation (Taiwan) announced today the execution of a new licensing agreement granting...

Feb 05, 2014, 09:25 ET

Kinex Appoints Executives To Clinical Leadership Team

Kinex Pharmaceuticals, (Kinex), a leading specialty biotech focused on the development and commercialization of next generation oral therapies for...

Dec 04, 2013, 10:00 ET

Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas

 Kinex Pharmaceuticals announced today that they have received Orphan Drug designation for KX02 for the treatment of gliomas, which are...

Oct 28, 2013, 08:55 ET

Kinex Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel

 Kinex Pharmaceuticals today announced that the first patient has been dosed in its Phase Ib Oraxol study.  Oraxol allows for oral...

Oct 22, 2013, 09:00 ET

Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan

 Kinex Pharmaceuticals and Hanmi Pharmaceutical Co., Ltd. are pleased to announce the execution of an agreement for Kinex Pharmaceuticals to...

Oct 15, 2013, 09:00 ET

Dr. Daniel Von Hoff, MD, F.A.C.P. Joins Kinex team as the Chair of the Clinical Advisory Committee

 Kinex Pharmaceuticals, a leading specialty biotech focused on the development and commercialization of next generation oral therapies for...

Sep 12, 2013, 13:27 ET

Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals

 Kinex Pharmaceuticals is pleased to announce that Dr. David Hangauer has formally accepted a full time role with the company as its Chief...

Aug 01, 2013, 09:00 ET

Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)

Kinex Pharmaceuticals is pleased to announce that their application for the Small Entrepreneur Research Assistance Programme has been approved by...

Jul 22, 2013, 09:52 ET

Kinex Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel that is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US

  Kinex Pharmaceuticals, Inc. announced today that the FDA has allowed its Investigational New Drug (IND) application for Oraxol. ...

Jul 09, 2013, 12:45 ET

Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China

 Kinex Pharmaceuticals and Hanmi Pharmaceutical Co., Ltd. are pleased to announce the execution of an agreement for Kinex Pharmaceuticals to...